Fmr LLC Kura Oncology, Inc. Transaction History

Fmr LLC

$1.52 Trillion
Q2 2024

A detailed history of Fmr LLC transactions in Kura Oncology, Inc. stock. As of the latest transaction made, Fmr LLC holds 68,518 shares of KURA stock, worth $1.39 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

68,518

Previous 64,673 5.95%

Holding current value

$1.39 Million

Previous $1.38 Million 2.25%

% of portfolio

0.0%

Previous 0.0%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	BUY	$17.53 - $22.98 $67,402 - $88,358	3,845 Added 5.95%	68,518 $1.41 Million
Q1 2024 May 13, 2024	BUY	$13.42 - $23.53 $2,670 - $4,682	199 Added 0.31%	64,673 $1.38 Million
Q4 2023 Feb 13, 2024	SELL	$7.58 - $14.38 $45,517 - $86,351	-6,005 Reduced 8.52%	64,474 $927,000
Q3 2023 Nov 13, 2023	BUY	$8.44 - $11.86 $36,418 - $51,175	4,315 Added 6.52%	70,479 $642,000
Q2 2023 Aug 11, 2023	BUY	$9.62 - $13.99 $243,626 - $354,296	25,325 Added 62.01%	66,164 $700,000
Q1 2023 May 11, 2023	BUY	$10.71 - $14.6 $15,861 - $21,622	1,481 Added 3.76%	40,839 $499,000
Q4 2022 Feb 13, 2023	SELL	$11.23 - $16.9 $308,431 - $464,158	-27,465 Reduced 41.1%	39,358 $488,000
Q3 2022 Nov 10, 2022	BUY	$12.01 - $19.45 $6,641 - $10,755	553 Added 0.83%	66,823 $913,000
Q2 2022 Aug 12, 2022	SELL	$10.71 - $18.33 $2,977 - $5,095	-278 Reduced 0.42%	66,270 $1.21 Million
Q1 2022 May 13, 2022	SELL	$11.78 - $16.98 $65 Million - $93.7 Million	-5,515,652 Reduced 98.81%	66,548 $1.07 Million
Q4 2021 Feb 14, 2022	SELL	$12.22 - $19.57 $7.85 Million - $12.6 Million	-642,573 Reduced 10.32%	5,582,200 $78.2 Million
Q3 2021 Nov 15, 2021	SELL	$15.42 - $21.72 $24.4 Million - $34.3 Million	-1,579,202 Reduced 20.24%	6,224,773 $117 Million
Q2 2021 Aug 13, 2021	BUY	$20.85 - $29.88 $163 Million - $233 Million	7,803,975 New	7,803,975 $163 Million

Others Institutions Holding KURA

# of Institutions

181

Shares Held

80.2M

Call Options Held

148K

Put Options Held

63K

View Full List

About Kura Oncology, Inc.

Ticker KURA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 66,893,000
Market Cap $1.36B
Description
Kura Oncology, Inc., a clinical-stage biopharmaceutical company, develops medicines for the treatment of cancer in the United States. The company's pipeline consists of small molecule product candidates that target cancer. Its lead product candidates are ziftomenib, a small molecule inhibitor of the menin-Lysine K-specific Methyltransferase 2A p...

More about KURA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Fmr LLC, based on Form 13F filings with the SEC.

News

Stay updated on Fmr LLC with notifications on news.

Account